Counterfeiting

(Image: Getty/Andrey Bukreev)

Looking to the future of a safe supply chain

By Ben Hargreaves

in-PharmaTechnologist (IPT) speaks to Ettore Cucchetti (EC), CEO of ACGI, about how the biopharma industry is adapting to the threat of counterfeit medicine and how he expects the industry will adopt further measures beyond those stipulated in the EU...

Follow us

Featured Events

View more

Products

View more

Webinars